Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

Patients with AML aged 80 years and older face poor survival despite treatment advances, highlighting the need for improved, ...

The hospital threatened "to get the law involved," his friend said. "You tell me how that’s right for a man that’s fighting ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...

Dana-Farber researchers identified factors predicting the success of donor lymphocyte infusion (DLI) in treating relapsed AML ...

A 7-year-old in Idaho is at the forefront of many minds in the Lewisville area, as her family and community plan a fundraiser ...

Columbia Engineering and Irving Institute researchers unveil a significant finding in cancer immunotherapy, uncovering unique ...

Junior guard Audrey Baxter lost her mom to acute myeloid leukemia last March. “I don’t know a lot of people that would be ...

Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

Cell types detected in the bone marrow of a responder patient pre-treatment (left) and post-treatment (right). Contour lines mark cell groups with similar spatial neighborhoods, highlighting ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...